Treace Medical Concepts Stock Quote TMCI - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

10.54

Bid

10.53

Ask

10.55

Volume

140,374

10.43 Day's Range 10.72

5.27 52 Week Range 27.70

Market Cap

650.899M

Previous Close

10.40

Open

10.48

Last Trade

100

10.54

Last Trade Time

14:02:22

Financial Volume

$ 1,482,153

VWAP

10.5586

Average Volume (3m)

399,909

Shares Outstanding

61,755,146

Dividend Yield

PE Ratio

-13.14

Earnings Per Share (EPS)

-0.8

Revenue

187.12M

Net Profit

-49.53M

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of ... Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.treace.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Treace Medical Concepts Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker TMCI. The last closing price for Treace Medical Concepts was $10.40. Over the last year, Treace Medical Concepts shares have traded in a share price range of $ 5.27 to $ 27.70.

Treace Medical Concepts currently has 61,755,146 shares outstanding. The market capitalization of Treace Medical Concepts is $650.90 million. Treace Medical Concepts has a price to earnings ratio (PE ratio) of -13.14.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.42	-3.83211678832	10.96	11.39	10.23	321296	10.61937687	CS
4	-2.5	-19.1717791411	13.04	13.24	10.23	313908	11.60327837	CS
12	-3.21	-23.3454545455	13.75	15.98	10.23	399909	13.08174109	CS
26	0.91	9.44963655244	9.63	15.98	5.27	699163	10.60057182	CS
52	-14.28	-57.5342465753	24.82	27.7	5.27	602205	13.5783074	CS
156	-19.06	-64.3918918919	29.6	37.17	5.27	383336	17.96219069	CS
260	-13.96	-56.9795918367	24.5	37.17	5.27	389283	18.15441297	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAUDCollective Audience Inc	$ 0.7119 (82.54%)	146.7M
DCPHDeciphera Pharmaceuticals Inc	$ 25.215 (72.12%)	42.03M
HWHHWH International Inc	$ 2.77 (52.20%)	27.27M
MULNMullen Automotive Inc	$ 4.73 (49.68%)	48.5M
SINTSiNtx Technologies Inc	$ 0.0559 (38.37%)	149.04M
CLVRClever Leaves Holdings Inc	$ 1.69 (-58.88%)	663.74k
ADXNAddex Therapeutics Ltd	$ 8.1164 (-49.59%)	140.21k
MFImF International Ltd	$ 1.5513 (-33.42%)	2.7M
TSDDGraniteShares ETF Trust GraniteShares	$ 17.16 (-31.08%)	1.3M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 27.17 (-30.81%)	6.7M
TSLATesla Inc	$ 194.43 (15.53%)	190.64M
SINTSiNtx Technologies Inc	$ 0.0559 (38.37%)	149.04M
CAUDCollective Audience Inc	$ 0.7119 (82.54%)	146.7M
SOFISoFi Technologies Inc	$ 7.0801 (-10.04%)	122.68M
NKLANikola Corporation	$ 0.6565 (2.04%)	72.68M